Anindita Chakrabarty

Greater Noida, UP, IN 
Greater Noida, UP, IN 

Overview

Anindita Chakrabarty practices practicing medicine in Greater Noida, India.

Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, Breast Cancer, and Morning Sickness.

She is actively involved in clinical research, co-authoring 32 peer reviewed articles.

Gender

Female

Locations

Greater Noida, UP, India
Other Locations
Gautam, UP 201314, India
Shiv Nadar Institution of Eminence, NCR
Delhi, DL, India
Nadar, UP 201314, India
Dadri, UP, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

32 Total Publications

Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS-CoV-2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir.
Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS-CoV-2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir.
Journal: Chembiochem : a European journal of chemical biology
Published: January 25, 2026

Frequently Asked Questions about Anindita Chakrabarty

Is Anindita Chakrabarty a top-rated expert for PIK3CA-Related Overgrowth Spectrum?

MediFind is an objective health platform that identifies experts based on real-world data. Anindita Chakrabarty is classified as an Experienced expert for PIK3CA-Related Overgrowth Spectrum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anindita Chakrabarty participate in research or clinical trials?

Yes. Anindita Chakrabarty has published 32 articles and abstracts on conditions like PIK3CA-Related Overgrowth Spectrum. You can view a list of Anindita Chakrabarty's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Chakrabarty's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile